Cardiff Lexington Corporation (CDIX)
OTC Markets OTCQX
Price as at 30 Sept 2026, 16:55 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Cardiff Lexington Corporation trades at $0.17. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Cardiff Lexington Corporation
Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates through two segments, Healthcare and Real Estate. The company provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. It also engages in real estate business. The company also offers orthopedic and pain procedure services, including hip and knee replacement, shoulder reconstruction, fracture care, and hand surgery, as well as spinal surgery. It serves personal injury attorneys, insurance carriers, physical therapy providers, and chiropractic care providers. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation is based in Lexington, Kentucky.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its CDIX data?
Fundamentals for CDIX come from company filings and exchange data, as listed on OTC Markets OTCQX; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 16:55 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for CDIX, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.